Success Stories: NAILG Overcame RFE to Secure Both NIW and EB-1A Approvals for Postdoctoral Scholar in Materials Science

Client’s Testimonial:

“Wegreened group was instrumental in getting my EB1A petition approved—even after an RFE. Their deep understanding of the EB1A process, strategic approach to presenting my achievements, and clear communication made all the difference. The response to the RFE was exceptionally well-crafted and directly addressed USCIS’s concerns. I’m incredibly grateful for their guidance and highly recommend them to anyone pursuing the EB1A path.”

On May 10^th, 2024, and May 13^th, 2025, we received another EB-2 NIW (National Interest Waiver) and EB-1A (Alien of Extraordinary Ability) approvals for a Postdoctoral Scholar in the Field of Materials Science (Approval Notice).

General Field: Materials Science

Position at the Time of Case Filing: Postdoctoral Scholar

Country of Origin: India

State of Residence at the Time of Filing: California

Approval Notice Date: : May 10^th, 2024 (NIW) and May 13^th, 2025 (EB1A)

Processing Time: 8 days (NIW) (Premium Processing Requested), and 2 months, 25 days (EB1A) (Premium Processing Requested)

Case Summary:

When our client approached NAILG for his EB-1A petition, he already had a strong foundation, having previously received NIW approval through our strategic support. Building on his earlier achievements, he sought EB-1A classification for his groundbreaking research in polymer engineering and soft robotics. His work in developing novel soft materials and their integration into advanced robotic and biomedical systems holds transformative potential, particularly for improving next-generation actuators, wearable technologies, and medical devices.

His innovations in materials science have broad implications across industries that rely on durable and adaptive materials, such as aerospace, healthcare, and energy. By bridging disciplines within robotics and functional materials, his research supports national priorities in medical technology and intelligent systems.

Our client’s academic accomplishments speak volumes about his leadership in the field:

● 12 peer-reviewed journal articles, including 5 first-authored

● 468 citations, establishing him as a recognized authority in polymer science

● 13 peer reviews, reflecting his standing within the academic community

● Funding from such prestigious organizations as the National Science Foundation, the Army Research Office, and the Office of Naval Research

While the petition initially faced a Request for Evidence (RFE), NAILG was quick to respond. We thoroughly addressed the USCIS concerns, presenting additional evidence to reinforce the impact and national relevance of our client’s work. Through NAILG’s expert strategy, we successfully navigated the RFE and ensured that his contributions to robotics and advanced materials were presented in the most compelling way possible, leading to the successful approval of the EB-1A petition.

An expert in the field summarized his impact:

“His methodologies are crucial for developing advanced materials pivotal in the evolution of soft robotics, biomedical devices, and responsive optical systems. Therefore, it is without reservation that I recommend [client], as I am confident that his ongoing work is fundamental to advancing the frontiers of materials science.”

NAILG is proud to have supported our client in securing his EB-1A and NIW approvals, allowing him to continue making significant strides in the fields of material science and robotics. We look forward to seeing his continued contributions to U.S. technological leadership.

North America Immigration Law Group (Chen Immigration Law Associates) is a U.S. immigration law firm dedicated to representing corporations, research institutions, and individuals from all 50 U.S. states regarding I-140 immigration petitions. We specialize in employment-based immigration petition and have a proven record of high success rate for the categories of: EB2-NIW (National Interest Waiver), EB1-A (Alien of Extraordinary Ability), EB1-B (Outstanding Researcher/Professor) and O-1 (Alien of Extraordinary Ability).

Our Ten Thousand I-140 Approvals Provide Unprecedented Insight into the USCIS Adjudication Trend

With more than 58,000 EB-1A, EB-1B, EB-2 NIW and O-1 cases approved, we have first hand information on the manner in which the USCIS adjudicate I-140 cases. As the USCIS has constantly changed its adjudication standards for the EB-1A, EB-1B and EB-2 NIW categories, our firm's huge database of successful cases gives you unprecedented insight to USCIS adjudication trends. We carefully analyze the data for all of our cases and apply the results of our analyses toward giving our clients up-to-date advice and adapting our strategies such that we remain on par with the ever-shifting landscape of immigration law in the U.S. With us, you will always have access to important updates, strategies, and information so that you can make the most informed decisions about your case.

We Have Helped Hundreds and Thousands of Clients with Credentials and Backgrounds Similar to Yours

With our exceedingly large number of successful petitions, no matter what credentials you have, no matter your background and field of expertise, no matter your visa status or nationality, chances are we have helped hundreds or even thousands of clients just like you. Our clients are usually impressed with how well we understand their research and work. Our insight and understanding stems from the fact that we have handled many cases with elements similar to yours already, and this helps us devise the best strategies for each individual petition.

Vast Majority of Clients Came to Us Because of Referrals

For years, our firm has attracted new clients based solely on word of mouth, recommendations, and the positive collaboration experiences shared with them by their friends and family. We take pride in our reputation and work hard to ensure that we provide a green card application experience that our clients are happy to share with their friends and colleagues. That is how our cumulative total of approved cases grew from 600 in 2013 to over 58,000 in 2025.